Armata Pharmaceuticals, Inc. Common Stock (ARMP)
Revenue Growth
-51.97%
TTM · Period ending:
ARMP Revenue Growth
Year-over-year change vs the same period a year earlier
Latest reported-51.97%period ending
Latest reported-51.97%period ending
ARMP TTM Revenue YoY % (66.67% → -51.97%)
Year-over-year change
High-resolution chart · PNG
ARMP revenue growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | Revenue Growth |
|---|---|
| -51.9656% | |
| -37.0504% | |
| -48.5891% | |
| -28.7543% | |
| 84.6733% | |
| 0% | |
| 14.2416% | |
| 34.921% | |
| -10.7083% | |
| -7.281% | |
| -17.7741% | |
| -25.5968% | |
| -22.2803% | |
| 9.1301% | |
| 23.1113% | |
| 36.5254% | |
| 77.0985% | |
| 145.8444% | |
| 443.6209% | |
| 1,150.4702% | |
| 9,661.2903% | |
| -100% | |
| -100% | |
| -100% | |
| -100% | |
| -82.906% | |
| -46.2963% | |
| -53.0055% | |
| -55.7692% | |
| -68.0328% | |
| -77.5% | |
| -61.7954% | |
| -45.2632% | |
| -17.9372% | |
| 18.2266% | |
| -21.987% | |
| -22.8896% | |
| -12.3772% | |
| 0.7444% | |
| 50.86% | |
| 89.5385% | |
| -87.4135% | |
| -94.5607% | |
| -95.5353% | |
| 16.8695% | |
| -9.9433% | |
| -26.231% | |
| -15.6214% | |
| -12.7878% | |
| -2.7131% | |
| 22.8147% | |
| 4.7445% | |
| 42.5641% | |
| 47.3126% | |
| 24.5208% | |
| 43.4972% | |
| -3.858% | |
| -19.6723% | |
| -29.307% | |
| -28.7816% | |
| 3.3767% | |
| -13.659% | |
| 5.9258% | |
| -31.4148% | |
| -54.4832% | |
| -38.6825% | |
| -50.2398% | |
| -27.2074% | |
| -13.7167% | |
| -17.5709% | |
| -4.1233% | |
| 2.3994% | |
| 34.8927% | |
| 32.5245% | |
| 56.871% | |
| 65.5705% | |
| 13.3349% | |
| 92.1629% | |
| 65.4984% | |
| 62.9% | |
| 15.6726% | |
| -18.72% | |
| -9.4828% | |
| -9.0909% | |
| 1,514.2857% | |
| 614.2857% | |
| 480% | |
| 381.25% | |
| -76.6667% | |
| -53.3333% | |
| -46.4286% | |
| -38.4615% | |
| 172.7273% | |
| 650% | |
| 600% | |
| 766.6667% | |
| 175% | |
| -20% | |
| -20% | |
| -40% |